Literature DB >> 15033231

The C-terminal antibody binding domain of Candida albicans mp58 represents a protective epitope during candidiasis.

Angel Viudes1, Anna Lazzell, Sofia Perea, William R Kirkpatrick, Javier Peman, Thomas F Patterson, Jose P Martinez, José L López-Ribot.   

Abstract

The 58-kDa surface mannoprotein of Candida albicans (mp58) elicits strong antibody responses during infection. Epitope mapping with sera from patients with candidiasis and control individuals indicated the presence of multiple IgG-reactive continuous epitopes on the protein, expanding both the amino- and carboxy-terminal domains and several internal regions. These immunoreactive regions were similar to the ones previously identified using sera from immunized animals. Two of the epitopic regions (including the C-terminal domain) showed increased reactivity with antibodies present in sera from patients with candidiasis as compared to control individuals. Patients who survived the infection displayed increased antibody reactivity towards the C-terminal epitope as compared to those succumbing to candidiasis. A monoclonal antibody directed towards this epitopic region conferred protection in serum therapy experiments in a murine model of hematogenously disseminated candidiasis. Together, these observations indicate the carboxy-terminal antibody binding domain of C. albicans mp58 represents a protective epitope during candidiasis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15033231     DOI: 10.1016/S0378-1097(04)00042-4

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  11 in total

1.  Human recombinant antimannan immunoglobulin G1 antibody confers resistance to hematogenously disseminated candidiasis in mice.

Authors:  Mason X Zhang; M Charlotte Bohlman; Carol Itatani; Dennis R Burton; Paul W H I Parren; Stephen C St Jeor; Thomas R Kozel
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

Review 2.  Candida albicans cell wall proteins.

Authors:  W LaJean Chaffin
Journal:  Microbiol Mol Biol Rev       Date:  2008-09       Impact factor: 11.056

Review 3.  The protective role of immunoglobulins in fungal infections and inflammation.

Authors:  Sri Ramulu Elluru; Srini V Kaveri; Jagadeesh Bayry
Journal:  Semin Immunopathol       Date:  2014-11-18       Impact factor: 9.623

Review 4.  Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases.

Authors:  Arturo Casadevall; Liise-Anne Pirofski
Journal:  Cell Host Microbe       Date:  2012-05-17       Impact factor: 21.023

5.  Influence of IgG Subclass on Human Antimannan Antibody-Mediated Resistance to Hematogenously Disseminated Candidiasis in Mice.

Authors:  Casey T Nishiya; Gayle M Boxx; Kerry Robison; Carol Itatani; Thomas R Kozel; Mason X Zhang
Journal:  Infect Immun       Date:  2015-11-16       Impact factor: 3.441

6.  Effect of tunicamycin on Candida albicans biofilm formation and maintenance.

Authors:  Christopher G Pierce; Derek P Thomas; José L López-Ribot
Journal:  J Antimicrob Chemother       Date:  2008-12-20       Impact factor: 5.790

7.  Analysis of PRA1 and its relationship to Candida albicans- macrophage interactions.

Authors:  A Marcil; C Gadoury; J Ash; J Zhang; A Nantel; M Whiteway
Journal:  Infect Immun       Date:  2008-07-14       Impact factor: 3.441

Review 8.  Adaptive immune responses to Candida albicans infection.

Authors:  Jonathan P Richardson; David L Moyes
Journal:  Virulence       Date:  2015-01-21       Impact factor: 5.882

Review 9.  Monoclonal Antibodies as Tools to Combat Fungal Infections.

Authors:  Sebastian Ulrich; Frank Ebel
Journal:  J Fungi (Basel)       Date:  2020-02-04

10.  Glycoconjugates and polysaccharides of fungal cell wall and activation of immune system.

Authors:  M R Pinto; E Barreto-Bergter; C P Taborda
Journal:  Braz J Microbiol       Date:  2008-06-01       Impact factor: 2.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.